Recombinant Brucella abortus Malate dehydrogenase protein (His tag) is a Brucella abortus S19 Full Length protein, in the 1 to 320 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE, MS.
M A R N K I A L I G S G M I G G T L A H L A G L K E L G D V V L F D I A E G T P Q G K G L D I A E S S P V D G F D A K F T G A N D Y A A I E G A D V V I V T A G V P R K P G M S R D D L L G I N L K V M E Q V G A G I K K Y A P E A F V I C I T N P L D A M V W A L Q K F S G L P A H K V V G M A G V L D S A R F R Y F L S E E F N V S V E D V T V F V L G G H G D S M V P L A R Y S T V A G I P L P D L V K M G W T S Q D K L D K I I Q R T R D G G A E I V G L L K T G S A F Y A P A A S A I Q M A E S Y L K D K K R V L P V A A Q L S G Q Y G V K D M Y V G V P T V I G A N G V E R I I E I D L D K D E K A Q F D K S V A S V A G L C E A C I G I A P S L K
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Catalyzes the reversible oxidation of malate to oxaloacetate.
BAbS19_I18080, mdh, Malate dehydrogenase
Recombinant Brucella abortus Malate dehydrogenase protein (His tag) is a Brucella abortus S19 Full Length protein, in the 1 to 320 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE, MS.
pH: 7.2 - 7.4
Constituents: Tris buffer, 50% Glycerol (glycerin, glycerine)
Catalyzes the reversible oxidation of malate to oxaloacetate.
Belongs to the LDH/MDH superfamily. MDH type 3 family.
Brucella abortus Malate dehydrogenase also known as MDH is an enzyme that plays a significant role in the citric acid cycle. This enzyme catalyzes the conversion of malate to oxaloacetate through the reduction of NAD+ to NADH. MDH has a molecular mass of approximately 32 kDa. Within the bacterial cells it is expressed in the cytoplasm where it participates in metabolic reactions critical for energy production.
The enzyme facilitates the energy transformation processes necessary for Brucella abortus to survive and replicate in host cells. It is not known to form part of a larger enzyme complex but interacts with other metabolic enzymes to ensure proper function of the tricarboxylic acid (TCA) cycle. Efficient operation of MDH is essential for providing the intermediates and reducing equivalents needed for other biological processes.
Malate dehydrogenase contributes to the functionality of the TCA cycle and the glyoxylate shunt. These pathways are important for the survival of Brucella abortus in nutrient-limited conditions such as inside host macrophages. Malate dehydrogenase works alongside other key proteins like citrate synthase and isocitrate lyase coordinating effectively to maintain cellular energy balance and metabolic flexibility.
Brucella abortus Malate dehydrogenase connects to brucellosis a zoonotic disease affecting various mammals including humans. The bacterium’s ability to proliferate within host cells partly depends on the activity of MDH and related proteins such as succinate dehydrogenase. Understanding this enzyme's role helps in devising therapeutic interventions aimed at inhibiting Brucella abortus' energy production thereby reducing infection rates and disease severity.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Based on the SEQUEST from database of E.coli host and target protein, the LC-MS/MS analysis result of ab224852 could indicate that this peptide derived from E.coli-expressed Brucella abortus (strain S19) mdh.
Based on the SEQUEST from database of E.coli host and target protein, the LC-MS/MS analysis result of ab224852 could indicate that this peptide derived from E.coli-expressed Brucella abortus (strain S19) mdh.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com